Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics

Abstract

Genetic association studies, in particular the genome-wide association study (GWAS) design, have provided a wealth of novel insights into the aetiology of a wide range of human diseases and traits, in particular cardiovascular diseases and lipid biomarkers. The next challenge consists of understanding the molecular basis of these associations. The integration of multiple association datasets, including gene expression datasets, can contribute to this goal. We have developed a novel statistical methodology to assess whether two association signals are consistent with a shared causal variant. An application is the integration of disease scans with expression quantitative trait locus (eQTL) studies, but any pair of GWAS datasets can be integrated in this framework. We demonstrate the value of the approach by re-analysing a gene expression dataset in 966 liver samples with a published meta-analysis of lipid traits including >100,000 individuals of European ancestry. Combining all lipid biomarkers, our re-analysis supported 26 out of 38 reported colocalisation results with eQTLs and identified 14 new colocalisation results, hence highlighting the value of a formal statistical test. In three cases of reported eQTL-lipid pairs (SYPL2, IFT172, TBKBP1) for which our analysis suggests that the eQTL pattern is not consistent with the lipid association, we identify alternative colocalisation results with SORT1, GCKR, and KPNB1, indicating that these genes are more likely to be causal in these genomic intervals. A key feature of the method is the ability to derive the output statistics from single SNP summary statistics, hence making it possible to perform systematic meta-analysis type comparisons across multiple GWAS datasets (implemented online at http://coloc.cs.ucl.ac.uk/coloc/). Our methodology provides information about candidate causal genes in associated intervals and has direct implications for the understanding of complex diseases as well as the design of drugs to target disease pathways.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 68

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

2. 2.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

3. 3.
   Pervasive Sharing of Genetic Effects in Autoimmune Disease · 2011

   No notice
4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

6. 6.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

7. 7.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

8. 8.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

9. 9.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

10. 10.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

12. 12.
    Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS · 2010

    No notice
13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

14. 14.
    Genotype Imputation with Thousands of Genomes · 2011

    No notice
15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

16. 16.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

17. 17.
    Mapping the Genetic Architecture of Gene Expression in Human Liver · 2008

    No notice
18. 18.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

19. 19.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

20. 20.
    Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies · 2011

    No notice
21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

23. 23.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

24. 24.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

25. 25.
    Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain · 2012

    No notice
26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

27. 27.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

28. 28.
    Practical Issues in Imputation-Based Association Mapping · 2008

    No notice
29. 29.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

30. 30.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

31. 31.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

32. 32.
    Integrative Modeling of eQTLs and Cis-Regulatory Elements Suggests Mechanisms Underlying Cell Type Specificity of eQTLs · 2013

    Corrected
33. 33.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

34. 34.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

35. 35.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

36. 36.
    The Metabochip, a Custom Genotyping Array for Genetic Studies of Metabolic, Cardiovascular, and Anthropometric Traits · 2012

    Corrected
37. 37.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

38. 38.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

39. 39.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

40. 40.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

Cited by papers we hold 111

• Advancing regulatory variant effect prediction with AlphaGenome · 2026
  No notice
• Characterizing aging-related genetic and physiological determinants of spinal curvature · 2025
  Not checked
• Genetically proxied inhibition of Phosphodiesterase-5 and cancer risks: A drug-target Mendelian randomization analysis · 2025
  Not checked
• European and African ancestry-specific plasma protein-QTL and metabolite-QTL analyses identify ancestry-specific T2D effector proteins and metabolites · 2025
  Not checked
• Potential drug targets for peripheral artery disease identified through Mendelian randomization analysis · 2025
  Not checked
• Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies · 2025
  No notice
• Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference · 2024
  No notice
• Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease · 2024
  No notice
• Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits · 2024
  No notice
• Large-scale plasma proteomics comparisons through genetics and disease associations · 2023
  Corrected
• Using genetic association data to guide drug discovery and development: Review of methods and applications · 2023
  No notice
• Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci · 2023
  No notice
• Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure · 2023
  No notice
• Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders · 2023
  No notice
• Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome · 2023
  No notice
• European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation · 2023
  No notice
• Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases · 2023
  No notice
• Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses · 2023
  No notice
• Whole-genome sequencing reveals host factors underlying critical COVID-19 · 2022
  No notice
• Stroke genetics informs drug discovery and risk prediction across ancestries · 2022
  Corrected

and 91 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.